Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Return on Sales (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Return on Sales for 2 consecutive years, with 246.75% as the latest value for Q4 2024.

  • For Q4 2024, Return on Sales fell 25239.0% year-over-year to 246.75%; the TTM value through Dec 2024 reached 246.75%, changed N/A, while the annual FY2024 figure was 260.45%, 25959.0% down from the prior year.
  • Return on Sales hit 246.75% in Q4 2024 for Artiva Biotherapeutics, down from 12.53% in the prior quarter.
  • Across five years, Return on Sales topped out at 5.64% in Q4 2023 and bottomed at 246.75% in Q4 2024.